Dandelion PFH333
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
D-Dimer PFH334
Includes:
Sample: Plasma- Na Citrated (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Dehydroepiandrosterone (DHEA) PFH335
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Dehydroepiandrosterone Sulphate (DHEAS) PFH336
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Dengue - NS1 Antigen PFH337
Includes:
Sample: Serum (1 ml)
Methodology: ImmunoChromatography
Reporting: 11:00/18:00
Dengue - RNA PCR - Qualitative PFH338
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 5 (11:00)
Dengue IgG PFH339
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Dengue IgM PFH340
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Dengue Profile ( IgG, IgM & NS1 Antigen) PFH341
Includes:
Sample: Serum (3 ml)
Methodology: ImmunoChromatography
Reporting: 11:00/18:00
Dermatophagoides farinae PFH342
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Dermatophatgodies pteronyssinus PFH343
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Desmoglein I PFH344
Includes:
Sample: Serum (1 ml)
Methodology: ELISA
Reporting: 3 (18:00)
Desmoglein III PFH345
Includes:
Sample: Serum (1 ml)
Methodology: ELISA
Reporting: 3 (18:00)
Differential Count (DC) PFH346
Includes:
Sample: WB-EDTA (3ml)
Methodology: Cell Counter/ Microscopy
Reporting: 11:00/19:00
Digoxin PFH347
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Diphtheria IgG PFH348
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 6 (19:00)
DNA Ploidy & S Phase - Leukemia PFH349
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
Dog Dander PFH350
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
DSA PFH351
Includes:
Sample: Donor:Two ACD whole Blood and single SST containing serum of receipient
Methodology: Luminex-X map technology
Reporting: 3 & 6 (19:00)
DUCHENNE MUSCULAR DYSTROPHY (DMD) (26 exons) PFH352
Includes:
Sample: Peripheral Blood in EDTA (3 ml)
Methodology: PCR
Reporting: 6 Days (11:00)
